*Q4 revenue $1.98 bln vs est $1.99 bln. *Sees FY earnings $1.03- $1.07/ share vs est $1.05. Feb 4- Heart device maker Boston Scientific Corp's quarterly revenue fell just shy of Wall Street expectations as sales in its second-biggest unit fell, sending its shares down as much as 6 percent.» Read More
The managing partner of Google's venture capital, Bill Maris, says under-investment in health sciences is short-sighted.
The goal is to enable physicians and pharmaceutical companies to use complex genetic data to tailor treatment on an individual basis, according to Mike Pellini, CEO of Foundation Medical.
Qualcomm's CEO Paul Jacobs says the smart phone will become a focal point for wirelessly connecting medical devices, diagnostics and sensors, and providing near real-time information.
The aging of America is taking a toll on the health care system. By 2050, the cost of treating Alzheimer's patients will hit $1 trillion a year.
Despite piles of research on the skin cancer risks of sun exposure and tanning beds, dermatologists and cancer groups struggle to persuade people to protect their skin from ultraviolet rays.
With 12 million Americans allergic to one food item or another, sales of specialty foods are soaring.
It was a complicated case, in part because the reform legislation itself was seriously flawed. The law’s drafters could have proposed a simpler and more efficient system, the New York Times reports.
What many business owners, analysts and experts say is that no matter what happens with the Supreme Court, some sort of closure is needed to the healthcare debate.
Physicians are embracing Web-based software solutions that are bringing healthcare services into the home.
Is legislated healthcare reform here to stay? As we watch the presidential race heat up – and look to a Supreme Court ruling this summer — no one knows for sure. Regardless, we as a nation need to realize that traditional thinking around healthcare is forever changed.
Check out his interview with CEO Dr. Phillip Frost.
While some people are frustrated about the long wait times for doctors appointments, some believe doctors are doing their jobs.
The federal government has received a surge in complaints in recent months about failed hip replacements, suggesting that serious problems persist with some types of artificial hips even as researchers scramble to evaluate the health dangers. The New York Times reports.
The market has given investors a great opportunity to buy this stock at discount, the "Mad Money" host said.
This secular growth name doesn't need a healthy economy to deliver healthy earnings growth, Cramer said.
The Centers for Disease Control considers obesity in America an epidemic; more than one out of three adults and 17 percent of all children are technically overweight to the point of obesity.
Spending a month in China earlier this year left me with a clear picture of a nation of rapid change, vast scale, and stark contrasts. All of these factors create opportunities – and challenges – for American businesses in China, and particularly for those of us in health care.
Personalized medicine has finally arrived and is poised to deliver significant health improvement and healthcare cost savings.
The government is making an increasing number of expensive life-saving or life extending drugs and devices available to more people, but is that the right thing to do and can we afford it, anyway?
Health care is an emotional subject for many Americans — and often one of extremes. Yet, as we obssess about the system's structure and cost, we neglect our own health. Obesity and high blood pressure are more common, while exercise and diet are overlooked. Our special report, "Healthy Business", explores these issues.